Cargando…

Safety of probiotics

Detalles Bibliográficos
Autor principal:	Kuitunen, Mikael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354316/ http://dx.doi.org/10.1186/2045-7022-1-S1-S9

Ejemplares similares

Substantiating efficacy of probiotics
por: Mercenier, Annick
Publicado: (2011)

Immunological and clinical effects of probiotics
por: Eigenmann, Philippe
Publicado: (2011)

Allergenicity assessment of GMOs by the European safety authority
por: Wal, Jean Michel
Publicado: (2011)

INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?
por: Mabbott, Donald
Publicado: (2022)

INSP-09. Using genetically engineered mouse models and patient-derived orthotopic xenografts to develop new therapies for pediatric brain tumors.
por: Jonchere, Barbara, et al.
Publicado: (2022)

INSP-04. Confirmatory adaptive designs for survival trials with several time-to-event endpoints
por: Schmidt, Rene
Publicado: (2022)

INSP-08. Cerebellar mutism syndrome: incidence, symptoms, risk factors, prognosis. Results and future perspectives from the Nordic-European study of the cerebellar mutism syndrome
por: Sehested, Astrid, et al.
Publicado: (2022)

INSP-03. Neuronal regulation of glioma progression
por: Monje, Michelle
Publicado: (2022)

INSP-17. Augmented Drug Delivery for Pediatric Diffuse Midline Glioma using Convection Enhanced Delivery
por: Souweidane, Mark M
Publicado: (2022)

INSP-14. Novel approaches to molecular diagnostics
por: Sahm, Felix
Publicado: (2022)

INSP-07. Improving cognitive outcomes for children treated for cancer: moving beyond the cure
por: Conklin, Heather
Publicado: (2022)

INSP-01. What to do when you cannot randomize? Leveraging Historical Data in Efficient Study Designs for Pediatric Neuro-Oncology.
por: Onar-Thomas, Arzu
Publicado: (2022)

INSP-02. WHO 2021 classification of CNS tumors
por: Wesseling, Pieter
Publicado: (2022)

INSP-16. Focused ultrasound-mediated blood-brain barrier disruption for the treatment of pediatric high-grade glioma
por: van Vuurden, Dannis, et al.
Publicado: (2022)

INSP-05. Development of fast cortical rhythms in health and mental disease
por: Hanganu-Opatz, Ileana
Publicado: (2022)

Conservative and surgical management of foot and ankle sporting injuries in the weekend warrior
por: Bedi, Harvinder S
Publicado: (2011)

Neurological disorders affecting the lower limb in children
por: Ryan, Monique
Publicado: (2011)

Evidence-based guidelines for the management of diabetic foot problems
por: Shaw, Jonathan
Publicado: (2011)

The national registration and accreditation scheme
por: Warnock, Jason, et al.
Publicado: (2011)

The acute response of tendon to loading: implications for rehabilitation
por: Wearing, Scott C, et al.
Publicado: (2011)

The heel fat pad: mechanical properties and clinical applications
por: Wearing, Scott C, et al.
Publicado: (2011)

Health workforce issues for podiatry
por: Brooks, Peter M
Publicado: (2011)

Recent advances in understanding the biomechanics of patellofemoral pain
por: Crossley, Kay M
Publicado: (2011)

Imaging-guided intervention of foot and ankle disorders
por: Koulouris, George
Publicado: (2011)

S4 prescribing for podiatrists
por: Marty, Stephen
Publicado: (2011)

The challenges of contemporary wound care
por: McGuiness, Bill
Publicado: (2011)

Podiatric surgery: friend or foe?
por: Prior, Trevor D
Publicado: (2011)

PASCOM
por: Prior, Trevor D
Publicado: (2011)

The practical application of biomechanical theory for patient assessment
por: Prior, Trevor D
Publicado: (2011)

Statistical validation of surrogate outcome measures
por: Buyse, Marc
Publicado: (2011)

Investigator led trials: challenges and opportunities
por: Sandercock, Peter
Publicado: (2011)

Seven myths of randomisation in clinical trials
por: Senn, Stephen
Publicado: (2011)

Adaptive designs: current status, future outlook
por: Grieve, Andy
Publicado: (2011)

Streamlining regulation of clinical trials – update on the Academy of Medical Sciences review and government’s response
por: Ford, Gary A
Publicado: (2011)

Using economic modelling to contribute to the prioritisation and design and clinical trials: ready for prime time
por: Sculpher, Mark
Publicado: (2011)

Strategies for handling missing data in randomised trials
por: White, Ian R
Publicado: (2011)

Patient reported outcomes: past, present, and future
por: Scott, Jane A
Publicado: (2011)

Identifying appropriate phase II trial designs
por: Brown, Sarah R
Publicado: (2011)

Adverse effects
por: Evans, Stephen JW
Publicado: (2011)

Trials in rare diseases: the need to think differently
por: Billingham, Lucinda, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_njn8i2n8onjqh22e1cm4qo51di